Aldeyra Therapeutics

$11.66
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.64 (+5.81%) As of 6:34 PM UTC today

Why Robinhood?

You can buy or sell ALDX and other stocks, options, and ETFs commission-free!

About ALDX

Aldeyra Therapeutics, Inc. operates as a biotechnology company. It primarily focuses on the development of new products for immune-mediated, inflammatory, orphan and other diseases that are thought to be caused in part by naturally occurring toxic chemical species known as free aldehydes.

CEO
Todd C. Brady
Employees
11
Headquarters
Lexington, Massachusetts
Founded
2004
Market Cap
584.76M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
547.01K
High Today
$11.70
Low Today
$10.93
Open Price
$11.05
Volume
195.55K
52 Week High
$14.62
52 Week Low
$2.50

ALDX Earnings

-$0.72
-$0.48
-$0.24
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, Pre-Market

You May Also Like

JQC
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure